Osimertinib, Targeted therapy, EGFR-TKI, 3rd Generation, Inhibits EGFR mutations, Central nervous system activity, NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation,
Sale!
Lucius
Replica of Osimertinib EGFR Ex19Del/L858R NSCLC Targeted Therapy
Original price was: $575.00.$416.00Current price is: $416.00.
Osimertinib, Targeted therapy, EGFR-TKI, 3rd Generation, Inhibits EGFR mutations, Central nervous system activity, NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation,